GlassScriptPhysician profile
Scott T Krull
NPI 1528489176
$4,213.46
in general payments reported to CMS, 2019-2025
42 companies · $836 in 2025
The $836 reported for 2025 was more than what 80% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $488 · 2022: $950 · 2023: $846 · 2024: $1,093 · 2025: $836.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,776.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,775.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $860.08 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $669.65 | 2021-2025 | |
| Lilly USA, LLC | $486.53 | 2021-2024 | Mounjaro, Jardiance, Zepbound |
| Amgen INC. | $408.52 | 2021-2025 | Evenity, Krystexxa, Prolia |
| Pfizer INC. | $295.19 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $137.67 | 2021-2025 | Breztri, Airsupra |
| Merck Sharp & Dohme LLC | $135.03 | 2021-2025 | Gardasil 9, Vaxelis, Vaxneuvance |
| Corium, LLC | $121.55 | 2022-2024 | Azstarys |
| Biohaven Pharmaceutical Holding Company LTD. | $89.70 | 2022 | |
| Novartis Pharmaceuticals Corporation | $67.88 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $65.78 | 2024-2025 | Rexulti |
| Daiichi Sankyo INC. | $58.18 | 2022-2025 | Vanflyta, Injectafer |
| Bayer Healthcare Pharmaceuticals INC. | $55.18 | 2022-2023 | |
| Alk-Abello, INC | $44.70 | 2024-2025 | Ragwitek, Odactra, Grastek |
| Seqirus USA INC | $44.39 | 2022-2024 | Fluad, Flucelvax |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Krull listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.